References in periodicals archive ?
To separate mixed indications from clear we defined function called "N-function".
Resonant inspection (RI) does not scan castings for an indication of a defect.
We still have a lot to do but, with one potential indication in hand and the results of two ongoing Phase II studies to come, we are increasingly confident that ThGRF will be a very important drug in the years ahead," Tanguay concluded.
Each panelist then reviewed the group's ratings and met with the others to discuss decisions and revise indications based on clinical knowledge.
In order to facilitate analysis, a questionnaire was developed, using as a guide the current indications for the use of low-osmolar agents by the Lourdes Hospital Radiology Group.
Girosa (flibanserin; Boehringer Ingelheim) - level of acceptable risk-benefit ratio varies with indications
Boehringer Ingelheim and InterMune plan to immediately seek expedited EU approvals for Imukin(R) for the treatment of severe, malignant osteopetrosis, an indication for which ACTIMMUNE(R) is already approved in the United States.
We are extremely pleased that the FDA has taken this step as we continue our efforts to expand the label indication for BioThrax to include, in combination with antibiotics, its use for post-exposure prophylaxis for anthrax infection," said Fuad El-Hibri, chairman and chief executive officer of Emergent BioSolutions.
The existing formulation of Phenylbutyrate is being initially developed for recurrent glioblastoma multiforme ("GBM"), an "orphan" indication.
Major companies are looking at different strategies in addition to new indications to protect sales of their products from generics.
The Cancer Market Outlook to 2011' provides detailed analysis on 9 indications in the cancer market, identifying growth brands, key drug classes and leading companies.
PETACH TIKVA, Israel -- Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has entered into an exclusive license agreement with a Japanese pharmaceutical company, Seikagaku Corporation, to develop and market CF101 in Japan for the treatment of inflammatory indications including rheumatoid arthritis (RA) but not including ophthalmic indications.